Editorially reviewed by Dr Fatimah Khan, registered with the Pakistan Medical and Dental Council (PMDC no. 104595-P). Editorial medical reviewer; does not prescribe or review patient assessments.
Review details
Review recorded:
Review scope: This article edition.
Editorial reviewer for Prescrivia. Editorial review does not establish participation in patient consultations.
Clinical review does not replace individual medical advice. Prescrivia is a technology intermediary; independent doctors make clinical decisions.
Legal review: Qualified review pending.
Language review: Qualified review pending.
Source and review
Source published:
Attributed source update:
Text edited:
Editorial role: Editorial team. This description does not establish an individual credential or clinical review of this edition.
Read our editorial policy and corrections. Edit dates and source descriptions do not establish qualified review.
How does Zyban help with stopping smoking?
Zyban contains bupropion, a prescription medicine used to support smoking cessation. It affects brain chemicals involved in cravings and withdrawal and does not contain nicotine. Its smoking-cessation indication should not be confused with other bupropion products prescribed for depression.
The UK Zyban product information specifies use with motivational support. A medicine can support a quit attempt; it does not guarantee that someone will stop smoking or remain smoke-free.
Understanding the course
The UK product information describes a seven-to-nine-week course, with a planned quit date and review of response. A prescriber chooses the regimen and checks whether an adjustment is needed. Prolonged-release tablets must not be cut, crushed or chewed.
Keep the written prescription and quit plan together. Ask when the review should happen and what to do if treatment is not helping. This guide does not offer a dose-escalation schedule to follow independently.
What results should you expect?
The NHS overview of nicotine-free medicines explains several available approaches, including bupropion, and the importance of additional support.
Trial success depends on participants, counselling, the definition of abstinence and follow-up duration. A percentage at the end of a course is not the same as sustained abstinence months later. Rather than attach unsupported quit-rate percentages to your own prospects, agree measurable goals with the clinician: cravings, adherence, smoking status and continued support.
Nicotine replacement and other medicines have different eligibility and adverse effects. There is no single option that is best or gentlest for everyone.
Why safety screening matters
Bupropion can cause insomnia, dry mouth and other adverse effects. The product information identifies dose-related seizure risk and contraindications including a seizure history, certain eating disorders, bipolar disorder and specific withdrawal or interacting-medicine situations. This summary is not a complete screening list.
Blood pressure may rise, particularly when treatment is combined with nicotine replacement. Do not add another stop-smoking medicine without advice. Report significant mood changes promptly; thoughts of self-harm require immediate help. Tell the clinician about all medicines, alcohol use, kidney or liver conditions and pregnancy or breastfeeding.
Preparing for a review
Bring a list of earlier quit attempts, medicines tried, side effects and available support. Ask which warning signs require urgent care and how progress will be reviewed.
See our explanation of independent online doctor assessment. Prescrivia is a technology intermediary; independent clinicians assess suitability. No medicine, access or quit outcome is guaranteed.
General information only, not medical advice. Follow the leaflet for your actual product and discuss decisions with a qualified clinician. See the current clinical, legal and language review statuses for this edition.
Sources
- GSK UK Zyban SmPC: smoking cessation with motivational support, duration, formulation, contraindications and seizure/mood/blood-pressure warnings.
- NHS information about nicotine-free smoking-cessation options and combining medicine with support.
Sources checked online on 6 October 2026. UK and US guidance is identified as such; it does not establish availability or prescribing rules across all European countries.